Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $138K | $0.00 | — | — | — | — |
| Revenue growth | — | -100.0% | — | — | — | — |
| Operating income | -$33.6M | -$156M | -$226M | -$159M | -$73.5M | -$78.6M |
| Operating margin | -24379.7% | — | — | — | — | — |
| Net income | -$37.7M | -$157M | -$223M | -$156M | -$74.1M | -$71.4M |
| Net margin | -27346.4% | — | — | — | — | — |
| EPS (diluted) | -$2.36 | -$1.48 | -$34.46 | -$24.00 | -$11.39 | -$10.70 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$29.6M | -$122M | -$180M | -$82.0M | -$55.7M | -$36.6M |
| Capital expenditures | $50.8M | $57.8M | $84.6M | $20.7M | $0.00 | — |
| Free cash flow | -$80.4M | -$180M | -$265M | -$103M | -$55.7M | — |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $242M | $37.6M | $43.7M | $9.20M | $8.80M | $6.64M |
| Total assets | $319M | $610M | $482M | $326M | $264M | $204M |
| Total liabilities | $26.6M | $54.8M | $119M | $99.8M | $94.1M | $89.7M |
| Shareholders' equity | -$39.6M | $555M | $364M | $226M | $169M | $114M |
| Retained earnings | -$44.9M | -$202M | -$425M | -$581M | -$655M | -$726M |
| Shares (wtd avg diluted) | 16.0M | 106M | 6.48M | 6.50M | 6.51M | 6.67M |
Every figure is extracted from Instil Bio, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.